Marché nord-américain de l’administration de médicaments – Tendances et prévisions du secteur jusqu’en 2030

Analyse et taille du marché de l'administration de médicaments en Amérique du Nord

Ces dernières années, le marché de l'administration de médicaments devrait augmenter au cours de la période de prévision. Selon l'OMS, l'incidence des maladies chroniques devrait augmenter de 57 % d'ici la fin de 2020. Les systèmes de santé se concentrent davantage sur les technologies avancées d'administration de médicaments, qui ont rapidement augmenté en réponse à l'augmentation des maladies chroniques. En outre, l'accent est de plus en plus mis sur la sécurité, l'efficacité et la convivialité des produits pour les patients.

Data Bridge Market Research analyse le taux de croissance du marché de l'administration de médicaments au cours de la période de prévision 2023-2030. Le TCAC attendu du marché de l'administration de médicaments a tendance à être d'environ 6,90 % au cours de la période de prévision mentionnée. Le marché était évalué à 720,57 milliards USD en 2022 et devrait atteindre 1 228,85 millions USD d'ici 2030. En plus des informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également une analyse approfondie des experts, l'épidémiologie des patients, l'analyse du pipeline, l'analyse des prix et le cadre réglementaire.

Portée et segmentation du marché de l'administration de médicaments en Amérique du Nord

Définition du marché

Drug delivery builds a therapeutic effect in a human's body by leading a drug to a certain targeted place. The safety and efficacy can be amplified by adjusting the rate, time, and release of the drug in the body. Drugs can be delivered in numerous ways, that includes oral, injectable, pulmonary, nasal, and other routes. The features of nanoparticles have been studied and used to develop drug delivery systems, making the drug distribution process more effective and time-saving.   

North America Drug Delivery Market Dynamics

Drivers

• Increase In The Occurrence Of Chronic Diseases

The increasing prevalence of chronic diseases is projected to propel the drug delivery market's growth. Obesity rates are increasing as a result of the rapid change in lifestyle, leading to a slew of chronic ailments such as diabetes and heart disease.

• Increasing Investment For Healthcare Infrastructure

A major factor prompting the growth rate of drug delivery market is the increasing healthcare expenditure that helps in improving its infrastructure.

Additionally, increasing initiatives by public and private organizations to spread awareness and technological advancement will enlarge the drug delivery market. Moreover, high disposable income and growing adoption of advanced drug administration systems will result in the expansion of drug delivery market.

•  Growing Elderly Population

Life expectancy is increasing around the world, that has led to a surge in the aging population. This trend positively impacts the industry by growing the occurrence of the disease and creating per capita demand for its remedies. Thus, this population demands high use of muscle relaxants and boosts market growth.

Opportunities

• Increase In The Number Of Research And Development Activities       

The market growth is driven by an increase in the number of research and development activities. This will provide advantageous opportunities for the drug delivery market growth. Along with this, increasing drug approvals and launch of innovative products will further boost the market growth rate.

• Rising Product Developments

Numerous product developments are initiated by several companies globally which are also accelerating the growth of market. For instance, in February 2020, Janssen Pharmaceutical Companies of Johnson & Johnson Services, Inc. told about the submission of a supplemental Biologics License Application (sBLA) to the U.S. FDA of DARZALEX along with Kyprolis and dexamethasone that is used to treat relapsed or refractory multiple myeloma.

Restraints/Challenges

• High Investment and Strict Regulatory Norms

The growth of the market is restricted by factors such as strict regulatory requirements and the risks associated with drug delivery systems. The use, separation, and development of raw materials for developing pharmaceutical and biopharmaceutical drugs demand professional and qualified personnel. Therefore, all these factors restrict the growth of the demand for the drugs.

This drug delivery market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the drug delivery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In 2022, Sandoz, a Novartis division, declared the acquisition of a U.K.-based medical and drug delivery device company, Coalesce Product Development Limited. Sandoz acquired Coalesce's expertise and assets as part of the arrangement, that will help the company to expand its respiratory medication portfolio and improve patient access to high-quality and complex therapeutics.

North America Drug Delivery Market Scope

The drug delivery market is segmented on the basis of type, route of administration, end-user, distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Conventional
• Advanced

Route of Administration

• Oral Drug Delivery
• Pulmonary Drug Delivery
• Injectable Drug Delivery
• Opthalmic Drug Delivery
• Nasal Drug Delivery
• Topical Drug Delivery
• Implantable Drug Delivery
• Transmucosal Drug Delivery

End-Users

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacies
• Others

North America Drug Delivery Market Regional Analysis/Insights

The drug delivery market is analyzed and market size insights and trends are provided by product type, end-user, and distribution channel as referenced above.

The major countries covered in the drug delivery market report are the U.S., Canada and Mexico in North America.

The U.S. is dominating in the North America region due to the increase in the adoption rate of several new technological advancements in the drug delivery. 

La section par pays du rapport fournit également des facteurs d'impact sur les marchés individuels et des changements de réglementation sur le marché national qui ont un impact sur les tendances actuelles et futures du marché. En outre, la présence et la disponibilité des marques mondiales et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, l'impact des tarifs nationaux et les routes commerciales sont pris en compte lors de l'analyse prévisionnelle des données nationales.   

Analyse du paysage concurrentiel et des parts de marché du secteur de la distribution de médicaments en Amérique du Nord

Le paysage concurrentiel du marché de l'administration de médicaments fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liée au marché de l'administration de médicaments.

Les principaux acteurs opérant sur le marché de l’administration de médicaments comprennent :

• F. Hoffmann-La Roche SA (Suisse)

• Mylan NV (États-Unis)
• Teva Pharmaceutical Industries Ltd. (Israël)
• Sanofi (France)
• Pfizer Inc. (États-Unis)
• GSK plc (Royaume-Uni)
• Novartis SA (Suisse)
• AstraZeneca (Royaume-Uni)
• Johnson & Johnson Private Limited (États-Unis)
• Sun Pharmaceutical Industries Ltd. (Inde)
• Merck & Co., Inc. (États-Unis)
• Lilly (États-Unis)
• 3M (États-Unis)
• Bayer AG (Allemagne)
• Astellas Pharma Inc. (Japon)
• AbbVie Inc. (États-Unis)
• Takeda Pharmaceutical Company Limited (Japon)

SKU-3047